Ticker: VKTX | Published: 2026-09-21
VKTX drifts lower calmly
Viking Therapeutics is slipping moderately on quiet, normal volume with low volatility, as an analyst reiterating its rating on potential maintenance trial data provides a stabilizing counterweight while weight-loss sector peers fall on competition fears.
Sources: https://www.investing.com/news/analyst-ratings/4908523, https://247wallst.com/investing/2026/0